Brief: Initiator Pharma Reports Q4 Net Revenue Of DKK 0.00
Feb 20 (Reuters) - Initiator Pharma A/S INIT.ST: Q4 NET REVENUE WERE KDKK 0 (0) Q4 OPERATING LOSS, EBIT WAS KDKK -6,966 (-2,701) BOARD OF DIRECTORS RECOMMEND THAT NO DIVIDEND IS PAID OUT FOR YEAR 2025 Source text: ID:nMFNbs306S Further company coverage: INIT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Initiator Pharma A/S
See all newsBrief: Initiator Pharma Q1 2026 Operating Loss DKK 11.4 Mln
Brief: Initiator Pharma To Fully Prioritize Pudafensine
Brief: Initiator Pharma Reports Q4 Net Revenue Of DKK 0.00
Brief: Initiator Pharma Q4 Operating Loss Widens To DKK 7 Mln
Brief: Initiator Pharma Granted European Patent For Pudafensine in FSD